432 Results (Page 1 of 18)
Canada Markets Research Reports
Canada ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
The Canada ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $2.365 Bn in 2022 to $3.287 Bn by 2030, registering a CAGR of 4.20% during the forecast period of 2022 - 2030. The number of individuals diagnosed with ADHD is on the rise, leading to a higher demand for ADHD medications. Some of the key players in the US ADHD drugs market include Shire (now part of Takeda), Johnson & Johnson, Novartis, Pfizer, Eli Lilly and Company, Concert Pharmaceuticals, Aevi Genomic Medicine, Neos Therapeutics, Vayarin, Supernus Pharmaceuticals.
Canada Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
Canada's Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $1.46 Bn in 2022 and is estimated to expand at a CAGR of 7.1% from 2022 to 2030 and will reach $2.52 Bn in 2030. One of the main reasons propelling the growth of this market is the increased prevalence rate, a result of government initiatives. The market is segmented by Drug class and by distribution channel. Some key players in this market are Abbott Laboratories, Adamis Pharmaceuticals Corporation, Almirall, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva Canada Limited, and others.
Canada Home Healthcare Market Analysis
Canada's home healthcare market is expanding at the market size of about $29 Bn in 2022 with a CAGR of 7.93% and is forecasted to grow up to $53 Bn in the year 2030 due to the aging population and the associated increase in disease rates. The Canada home healthcare market analysis is segmented by device type, service type, and by indication type. Johnson and Johnson, Omron Healthcare, and 3M Healthcare are the major players in the home healthcare market.
Canada Central Nervous System (CNS) Therapeutics Market Analysis
The Canada Central Nervous System (CNS)Therapeutics Market was valued at US $16.8 Bn in 2022 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to US $27.596 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of CNS diseases, supportive government initiatives, and technological factors. The industry is primarily dominated by players such as Pfizer, Novartis, Teva Pharmaceutical, Otsuka, AbbVie, Roche, and Eli Lilly among others.
Canada Telemedicine Market Analysis
The Canada Telemedicine market was valued at $4.864 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 18.2% from 2022 to 2030 and will reach $18.532 Bn in 2030. One of the main reasons propelling the growth of this market is the advent of advanced technologies, rising cases of chronic and lifestyle related disease. The market is segmented by end user, product type and Delivery mode. Some key players in this market are Cerner Corporation, GE Healthcare, Physiotherapy Ltd etc.
Canada Pharmaceutical Market Analysis
Canada's pharmaceutical market size is about $83.08 Bn in 2022 and is expected to witness significant growth of about $141.69 Bn in 2030 with a CAGR of 6.9% as there are a large number of overseas pharmaceutical companies having a presence in Canada. The incidences of chronic diseases among the Canadian population and comorbidities associated with the diseases are likely to positively impact the growth of the pharmaceutical market over the forecast period. The market is segmented by formulation type, route of administration type and prescription type, etc. Some of the leading players in the market are Pfizer, Novartis AG, and Roche.
Canada Physiotherapy Market Analysis
Canada's physiotherapy market size was valued at $4.25 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.85% from 2022 to 2030 and will reach $6.70 Bn in 2030. The Canada physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The major players in the Canada physiotherapy market are BTL Industries, Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.
Canada Pain Management Devices Market Analysis
This report presents a strategic analysis of the Canada Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Pain Management Devices Market, offering unmatched value, accuracy, and expert insights.
Canada Primary Hyperoxaluria (PH) Drugs Market Analysis
Canada Primary Hyperoxaluria (PH) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Unmet Medical Need, Increasing Awareness and Diagnosis, Advancements in Research and Development, Growing Investment and Pipeline Development, Collaboration and Patient Advocacy,rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Drugs Market are Allena Pharmaceuticals, Inc., Intellia Drugs, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
Canada Castrate Resistant Prostate Cancer Therapeutics Market Analysis
Canada Castrate Resistant Prostate Cancer Therapeutics Market valued at $816 Mn in 2022, projected to reach $1413 Mn by 2030 with a 7.10% CAGR. The key drivers of growth include the persistent unmet medical need for a cure, which fuels extensive research and development efforts for innovative treatments, as well as the transformative impact of technological innovations such as precision medicine, and a shift towards patient-centric priorities focusing on improved quality of life and less intrusive treatment options. The Canada Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Bayer, Roche, Sanofi, Novartis, AstraZeneca, Apotex, Paladin Labs, Bausch etc, among various others.
Canada Alzheimer’s Therapeutics Market Analysis
Canada Alzheimer’s therapeutics market was valued at $384 Mn in 2022 and is estimated to reach $771 Mn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The rising prevalence of Alzheimer's disease and the approval of therapies that modify the illness are expected to propel the market's growth. Biogen, Eisai, Roche, Novartis, Pfizer, Eli Lilly, Johnson & Johnson, AbbVie, AstraZeneca and Lundbeck are top leading pharmaceutical companies that are presently operating in the market
Canada Infectious Disease Drugs Market Analysis
Canada Infectious Disease Drugs Market valued at $9.5 Bn in 2023, projected to reach $12.73 Bn by 2030 with a 4.27% CAGR. The market is driven by factors such as rising rates of infectious diseases, technological developments in medication development, and expanding healthcare infrastructure and awareness. The market is dominated by key players like Gilead Sciences, AbbVie Inc., GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, Pfizer Inc., and Sanofi.
Canada Atopic Dermatitis Therapeutics Market Analysis
The Canada Atopic Dermatitis Therapeutics Market was valued at US $0.984 Bn in 2022, and is predicted to grow at (CAGR) of 8.8% from 2023 to 2030, to US $1.93 Bn by 2030. The key drivers of this industry include the rising prevalence of Atopic Dermatitis (AD), expansion in healthcare coverage and supportive government initiatives. The industry is primarily dominated by players such as Sanofi, AbbVie, Pfizer, Leo Pharma, Novartis among others.
Canada Atherosclerosis Therapeutics Market Analysis
Canada Atherosclerosis Therapeutics Market was valued at $224 Mn in 2022 and is estimated to reach $349 Mn in 2030, exhibiting a CAGR of 5.7% during the forecast period. The increasing prevalence of cardiovascular diseases, driven by the global aging population and rising occurrences of sedentary behaviour and unhealthy diets, is expected to fuel the demand for atherosclerosis therapeutics. The leading pharmaceutical companies currently operating in the industry are Pfizer, Novartis, AstraZeneca, Sanofi, Bayer, Johnson & Johnson, Eli Lilly, AbbVie, Roche and Teva Pharmaceutical Industries
Canada HIV Drugs Market Analysis
Canada HIV Drugs Market is at around $2.54 Bn in 2023 and is projected to reach $3.25 Bn in 2030, exhibiting a CAGR of 3.6% during the forecast period. The market is growing due to the prevalence of HIV/ AIDS, government initiatives and funding, and advancements in drug therapies. The market is dominated by key players like ViiV Healthcare, Gilead Sciences, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., F. Hoffman-La Roche Ltd., Cipla, Teva Pharmaceutical Industries Ltd., and Johnson & Johnson.
Canada Antifungal Drugs Market Analysis
Canada Antifungal Drugs Market is at around $1.3 Bn in 2023 and is projected to reach $1.6 Bn in 2030, exhibiting a CAGR of 3.8% during the forecast period. The market is growing due to the prevalence of fungal infections, consumer awareness and education, and partnerships and collaborations. The market is dominated by key players like Apotex Inc., Paladin Labs Inc., Abbott Laboratories, Merck & Co., Inc., Astellas Pharma Inc., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, and Glenmark Pharmaceuticals Limited.
Canada Alopecia Drugs (Hair Loss) Market Analysis
Canada alopecia drugs (hair loss) market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of alopecia, rising awareness and consciousness among individuals about their appearance, and the development of advanced treatment technologies. Johnson & Johnson, Merck & Co., GlaxoSmithKline plc, Cipla Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Histogen Inc., Aclaris Therapeutics, and Concert Pharmaceuticals are the key players in this market.
Canada Aminoglycosides Market Analysis
Canada Aminoglycosides Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The Aminoglycosides market is a segment of the pharmaceutical industry that focuses on the production and sale of aminoglycoside antibiotics. Key factors driving the market include the increasing prevalence of bacterial infections, especially drug-resistant strains, which require potent antibiotics like aminoglycosides. The growing geriatric population and the rise in chronic diseases also contribute to the demand for aminoglycosides. The market analysis also considers restraints such as the potential side effects and toxicity associated with aminoglycoside use. These antibiotics can cause serious adverse effects, including kidney damage and hearing loss, which limit their long-term use. Furthermore, the emergence of alternative antibiotics and the growing concern over antibiotic resistance pose challenges to the market growth. Some of the prominent global players in the Aminoglycosides market include Pfizer Inc., Merck & Co., Inc., Novartis AG, Bristol Myers Squibb Company, Eli Lilly and Company, Abbott Laboratories, Johnson & Johnson, Aurobindo Pharma Ltd., Teva Pharmaceutical Industries Ltd., and Mylan N.V.
Canada Anti-Aging Drugs Market Analysis
Canada Anti-Aging Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The Anti-Aging Drugs market is driven by the increasing aging population, advancements in medical research, growing consumer awareness and beauty standards, and the emphasis on preventive healthcare, prompting individuals to seek effective solutions for maintaining a youthful appearance and improving overall well-being. However, the Anti-Aging Drugs market also faces certain restraints. These include stringent regulatory requirements, potential safety concerns, and ethical considerations associated with the use of anti-aging drugs. Additionally, the high cost of some anti-aging drugs may limit their accessibility to a wider population. The Anti-Aging Drugs market is highly competitive, with several key players contributing to its growth and development. Companies such as Allergan, Galderma, Merz Pharma, and Johnson & Johnson are renowned for their expertise in developing and manufacturing anti-aging drugs and treatments.
Canada Anti-Venom Market Analysis
Canada Anti-Venom Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Purified antibodies are used to prevent snake venom from attaching to tissues and causing severe allergic reactions, blood clotting, muscular injury, or nervous system difficulties. The anti-venom market is being driven by the rising global incidence of snakebites, which is fueling demand for effective snakebite treatment options such as anti-venom products. Anti-venom awareness and education efforts have been critical in emphasising the necessity of anti-venom in snakebite management. Manufacturing and delivery techniques advancements have enhanced the safety, efficacy, and accessibility of anti-venom medications. However, market obstacles include restricted access in rural places, high manufacturing costs, a lack of specificity and efficacy in particular formulations, and safety concerns about potential adverse responses and difficulties during therapy.Some global players in the anti-venom market include CSL Limited, BTG plc, Merck & Co., Inc., Pfizer Inc., Sanofi Pasteur SA, Haffkine Bio-Pharmaceutical Corporation Ltd., Rare Disease Therapeutics, Inc., Instituto Bioclon, S.A. de C.V., and Bharat Serums and Vaccines Limited.
Canada Anticoagulants Market Analysis
Canada Anticoagulants Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Anticoagulants, commonly known as blood thinners, reduce the risk of blood clots and related consequences by suppressing the clotting mechanisms in the blood. Increased cardiovascular illnesses, an ageing population, greater awareness, technical improvements, advantageous reimbursement policies, and an increase in surgical operations are driving the anticoagulants market. However, there are hazards of bleeding, regulatory requirements, and generic alternatives. The presence of many prominent companies who play a crucial part in developing the industry characterises the global anticoagulants market. Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company, Limited, Sanofi S.A., Novartis AG, Merck & Co., Inc., and Portola Pharmaceuticals, Inc. are among the prominent participants.
Canada Antiepileptics Drugs Market Analysis
Canada Antiepileptics Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Epilepsy is a chronic neurological disorder characterized by recurrent seizures. The market for antiepileptic drugs is driven by the growing prevalence of epilepsy worldwide and the continuous need for effective and well-tolerated medications. Continuous advances in drug research and development help to bring new and improved antiepileptic treatments to market. These developments result in the creation of pharmaceuticals with improved efficacy, safety profiles, and fewer side effects, which drives market expansion. Some prominent players in the market include UCB Pharma, GlaxoSmithKline plc, Pfizer Inc., Novartis AG, Johnson & Johnson, Sanofi S.A., Eisai Co., Ltd., Sunovion Pharmaceuticals Inc., Cephalon, Inc., and Teva Pharmaceutical Industries Ltd.
Canada Antithrombotic Drugs Market Analysis
Canada Antithrombotic Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of cardiovascular disorders, growing geriatric population, developments in medication research, supportive government initiatives and advantageous reimbursement regulations for antithrombotic drugs drive market expansion. The antithrombotic drugs market is dominated by several key players who play a crucial role in driving advancements in the field of cardiovascular medicine. These key players include renowned pharmaceutical companies such as Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi Sankyo Company, Limited, Portola Pharmaceuticals, Inc., AstraZeneca PLC, and Bayer AG.
Canada Asthma Drugs Market Analysis
Canada Asthma Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for asthma drugs is primarily driven by the increasing prevalence of asthma globally, Growing awareness among patients and healthcare providers about the importance of asthma management and the availability of effective treatment options further fuel market growth. Key players in the asthma drugs market include pharmaceutical companies such as GlaxoSmithKline, Roche, AstraZeneca, Novartis, Merck & Co., and Teva Pharmaceutical Industries.
Canada Atherosclerosis Drugs Market Analysis
Canada Atherosclerosis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The atherosclerosis drugs market is driven by factors such as the rising prevalence of cardiovascular diseases, advancements in drug development, and growing awareness about early diagnosis and treatment. The key players in the atherosclerosis drugs market include Pfizer Inc., AstraZeneca PLC, Novartis AG, Bristol-Myers Squibb Company, Sanofi S.A., Merck & Co., Inc., Amgen Inc., Eli Lilly and Company, Bayer AG, and GlaxoSmithKline PLC.